Sex Determination & Reproductive Axis Development; Transgender Medicine (posters)


LRH-1 Is Able to Rescue SF-1 Deficiency in Steroidogenesis in Vitro but May Not Explain the Broad Phenotype of SF-1 Deficiency in Men
Nuria Camats, Laura Audí, Mónica Fernández-Cancio, Pilar Andaluz, Primus E Mullis, Antonio Carrascosa and Christa E Flueck


Early Medical Treatment of Children with Gender Dysphoria: An Empirical Ethical Study on Arguments of Proponents and Opponents Concerning Early Interventions
Martine de Vries, Lieke JJJ Vrouenraets, Anne B Wichmann, Maartje HN Schermer, Miranda Fredriks and Henriette Aleida Delemarre


Inherited Digenic Missense Variants in FGFR2 and MAP3K1 Genes in Two Siblings with 46,XY Partial Gonadal Dysgenesis
Aline Zamboni Machado, Mirian Y Nishi, Elaine Maria Frade Costa, Berenice B Mendonca and Sorahia Domenice


High Prolactin Levels in Transsexual Women Are Related to the Anti-Androgen Treatment Modality
Yael Sofer, Nir Sharon, Mariana Yaron, Michal Yacobi Bach, Iris Yaish, Naftali Stern and Yona Greenman


GnRH Analogue's Use in the Diagnostic Approach of Patients with Suspected 46,XX Ovotesticular Disorders of Sex Development
Tatiana S Pelaes, Nathalie Oliveira Santana, Rosana Barbosa Silva, Elaine Maria Frade Costa, Maria Helena Palma Sircili, Flávia Siqueira Cunha, Berenice B Mendonca and Sorahia Domenice


FOXL2 Transcriptionally Represses Sf1 Expression By Antagonizing WT1 during Ovarian Development in Mice
Kei Takasawa, Emanuele Pelosi, Masatoshi Takagi, Tomohiro Morio, Hiroshi Asahara, David Schlessinger, Shuki Mizutani, Peter Koopman and Kenichi Kashimada


The Epidemiology of Males with 46,XX Disorder of Sex Development ; A Nationwide Cohort Study
Agnethe Berglund, Kirstine Stochholm, Mette hansen Viuff and Claus H. Gravholt